Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti... see more

CSE:ASEP - Post Discussion

Asep Medical Holdings Inc > Sepsis - the #1 complication causing death in COVID patients
View:
Post by XeniaTechie on Dec 07, 2021 1:23pm

Sepsis - the #1 complication causing death in COVID patients

The pandemic is driving a growing unmet need when it comes to addressing the dramatic impact of sepsis deaths, which is still the #1 complication causing death among COVID-19 patients. Across overall statistics, sepsis kills over 11M people per year with 1:5 afflicted with sepsis dying to it. 


There’s a seriously massive opportunity with ASEP Medical Holdings operating across their subsidiaries ABT Innovations and Sepset Biosciences who are developing and testing a treatment for biofilms which account for 65% of all bacterial infections causing Sepsis in addition to a rapid test to accurately identify severe sepsis, saving many more lives. 


Definitely a very interesting and promising play, currently trading at .73, one to watch for sure as many early investors are still holding and in no rush to sell. Learn more about them in the video introducing new IPOs: https://youtu.be/xwr1rxwuWSk?t=763.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities